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ABSTRACT Rory de Vries works in the field of viral pathogenesis and focuses on in-
teractions between respiratory viruses (or corresponding vaccines) and the host im-
mune system. In this mSphere of Influence article, he reflects on how the articles
“Predominant infection of CD150 lymphocytes and dendritic cells during measles
virus infection of macaques” by R. L. de Swart et al. (R. L. de Swart, M. Ludlow, L. de
Witte, Y. Yanagi, et al., PLoS Pathog 3:e178, 2007, https://doi.org/10.1371/journal.ppat
.0030178) and “Long-term measles-induced immunomodulation increases overall child-
hood infectious disease mortality” by M. J. Mina et al. (M. J. Mina, C. J. Metcalf, R. L. de
Swart, A. D. M. E. Osterhaus, and B. T. Grenfell, Science 348:694–699, 2015, https://doi
.org/10.1126/science.aaa3662) made an impact on him. These articles studied interac-
tions between measles virus and the host and influenced him by making two important
points. (i) It is crucial to use nonadapted (recombinant) viruses in disease-relevant
model systems when studying virus-host interactions. (ii) Studying viral pathogenesis
requires a combination of in vitro, ex vivo, and in vivo studies, and a group of
researchers with multiple expertises. He learned that only when all these aspects are
combined, can one truly answer the question: “How does a virus cause disease?”
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In 2007, 1 year before starting my Ph.D. on measles pathogenesis and immunesuppression, R. L. de Swart and coworkers published an “illuminating” article on the
pathogenesis of measles (1). In this article, nonhuman primates were inoculated with a
recombinant wild-type-based measles virus (MeV) expressing a fluorescent reporter
protein, and viral tropism and pathogenesis were studied. Interestingly, this article was
preceded by an inconsistency in the literature: according to the textbooks, MeV initially
infected epithelial cells of the respiratory tract, followed by viremia predominantly
mediated by monocytes. However, neither of these cell types expressed the known
cellular entry receptor for MeV (at that time): signaling lymphocyte activation molecule
(SLAM, CD150) (2). de Swart et al. set out to address this inconsistency by performing
in vivo studies in the only animal model that fully recapitulates measles in humans,
nonhuman primates (3–6).
Before the identification of CD150 as the cellular entry receptor for MeV, the virus
was classically isolated on human kidney cells, Vero cells, or chicken embryo fibroblasts,
none of which express the receptor for MeV. Forced sequential passaging of MeV over
nonsusceptible cells led to laboratory adaptation and attenuation, creating the foun-
dation of the live-attenuated measles virus vaccines that are currently in use (7). It was
not all good news though: many scientists started using these laboratory-adapted
viruses to study virus-host interactions. Among other things, this led to the initial
identification of CD46 as a MeV receptor (8). We now know that CD46 can be used only
by laboratory-adapted and vaccine strains of MeV, but not by wild-type strains. Coming
back to the de Swart et al. article (1), to accurately study measles pathogenesis, it was
crucial that they selected a wild-type-like MeV strain that used the correct entry receptors
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(9). In addition, the recombinant virus used expressed a fluorescent reporter protein,
enhanced green fluorescent protein (EGFP) (10). The selection of this virus was inspired by
an article by von Messling et al., who studied the pathogenesis of canine distemper virus
by inoculating ferrets with an EGFP-expressing virus (11). The outcome of these studies was
truly amazing; both von Messling et al. (11) and de Swart et al. (1) were able to study viral
pathogenesis and tropism by visualizing EGFP-positive virus-infected cells and demonstrat-
ing virus replication on a macroscopic, microscopic, and single-cell level.
This work influenced me directly, because it made it possible to study one of my
major interests: how does MeV interact with the host immune system and cause
immune suppression? At this point in time, it was generally accepted that measles
causes a transient immune suppression; however, the underlying mechanisms and
duration were unclear. I studied the underlying mechanisms in vitro in human primary
cells and in vivo in nonhuman primates and found that MeV mainly targets memory T
lymphocytes and B lymphocytes, making the host “forget” previous infections. The
laboratory I worked in named this “measles immune amnesia” (12, 13). Shortly after
publication of these studies, M. J. Mina and coworkers published an impressive article
in Science on the public health consequences of measles immune amnesia (14). He
performed a retrospective clinical cohort-based study and proved that the incidence of
measles is directly associated with long-term (2 to 3 years after measles) noninfectious
disease mortality in children. To me, the article by Mina et al. also showed that only by
combining data from in vitro, ex vivo, in vivo models with clinical studies can one truly
answer the question “How does a virus cause disease?”
In a broader context, these articles have taught me an incredible amount about
studying viral pathogenesis and virus-host interactions. The differences in receptor use
between laboratory-adapted and wild-type MeV are a beautiful example of why I stress
that scientists should pay careful attention to which viruses they use in their studies.
Passaging of viruses on nonnatural target cells leads to adaptation, potentially influ-
encing results obtained from experiments with that passaged virus. Similarly, it has
taught me to make rational choices when selecting the cell type or animal model in
which I perform experiments. Performing in vitro experiments in continuous tumor cells
is often easy, because these cells are readily available and easy and cheap to maintain.
However, depending on the experimental question, I always consider the influence of
the choice of cell type on the results and whether it might be better to perform in vitro
(or ex vivo) experiments in primary cells. I have implemented these lessons in our
current studies on virus-host interactions of human respiratory syncytial virus (HRSV),
where we make use of recombinant viruses directly based on clinical isolates and study
their behavior in respiratory organoids or differentiated primary airway epithelial cells
cultured at the air-liquid interphase (15). This all sums up to a quote from Alessandro Sette
(La Jolla Institute for Immunology, San Diego, CA, USA) that I picked up while working there
as a visiting scientist: “Don’t do the experiments you can do (because of ease), but do the
experiments that you should do (using disease-relevant model systems).”
Both articles described here were game-changers in the field of measles research;
combined with follow-up studies, they led to revisions of the textbooks. Shaping me as
a researcher, this is one of the “life lessons” I have taken from these articles: what you
read in textbooks or articles is not right per se (or as my Ph.D. supervisor, Albert
Osterhaus, used to say, “Expect the unexpected”), and scientists should always remain
vigilant and “critical.” If one has a hypothesis that deviates from the current dogma, you
should be ambitious and perform the experiments to either prove or disprove that
hypothesis with perseverance and indomitable spirit.
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